首页 | 本学科首页   官方微博 | 高级检索  
     

高同型半胱氨酸血症与血管性疾病
引用本文:郭晓静,王淑秀,杨瑞. 高同型半胱氨酸血症与血管性疾病[J]. 新乡医学院学报, 2007, 24(1): 102-105
作者姓名:郭晓静  王淑秀  杨瑞
作者单位:新乡医学院病理学教研室
基金项目:河南省科技厅科技攻关项目
摘    要:高同型半胱氨酸血症(HCH)是冠状动脉疾病、脑血管疾病及外周血管疾病独立的危险因子,尽管其致病机制目前尚未完全明了,但是随着资料的累积和研究的深入HCH与血管性疾病的关系将得到进一步阐明,这无论是在理论还是实践上,对血管性疾病的防治具有十分重要的意义。作者通过综述近年来国、内外相关文献,以了解HCH引起的血管性疾病及其机制的研究现状。

关 键 词:同型半胱氨酸  血管性疾病  高同型半胱氨酸血症
文章编号:1004-7239(2007)01-0102-04
收稿时间:2006-10-18
修稿时间:2006-10-18

Hyperhomocysteinema and vascular disease
GUO Xiao-jing,WANG Su-xiu,YANG Rui. Hyperhomocysteinema and vascular disease[J]. Journal of Xinxiang Medical College, 2007, 24(1): 102-105
Authors:GUO Xiao-jing  WANG Su-xiu  YANG Rui
Affiliation:Department of Pathology, Xinxiang Medical College, Xinxiang 453003, China
Abstract:Hyperhomocysteinema(HCH) was an individual risk fact coronary artery disease,erebrovascular disease and peripheral vascular disease.Although the pathogenic mechanism was unclear,with cumulative data and research about HCH and vascular disease and the relation between them would be ascertained.It was the very important significance for prevention and treatment of vascular disease in view of theory or practice.Recent domestic and foreign papers were reviewed for learning recent advance on vascular disease and HCH and pathogenic mechanism.
Keywords:homocysteine  vascular disease  hyperhomocysteinema
本文献已被 CNKI 维普 万方数据 等数据库收录!
点击此处可从《新乡医学院学报》浏览原始摘要信息
点击此处可从《新乡医学院学报》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号